Skip to main content
Premium Trial:

Request an Annual Quote

William Parrett, Jason Novi, Robert Gavin, Wilhelm Lachnit, Tim Harkness

Premium
Thermo Fisher Scientific last week announced the election of William Parrett to its board.
 
Parrett has been appointed to the company’s audit committee.
 
Until his retirement last year, Parrett was at Deloitte Touche Tohmatsu for more than 40 years, most recently as global CEO.
 

 
Cell BioSciences this week announced Jason Novi has joined the company as its CFO. Also, Robert Gavin was named vice president, engineering, and Wilhelm Lachnit was named vice president, R&D.
 
Novi will be responsible for the finance, manufacturing, and administrative functions of the firm. Prior to Cell BioSciences, he was vice president of finance at Nektar Therapeutics. Between 2000 and 2007, he was director of finance at Molecular Devices.

Gavin was most recently director of engineering at MDS Analytical Technologies. Lachnit had most recently been at Molecular Devices where he held both scientific and commercial leadership positions.

Cell BioSciences is a startup nanofluidic systems firm. Last month it named Tim Harkness its president and CEO.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.